In the present study, the inosine intervention dramatically up-regulated the expressions of ZO-1, occludin, and claudin-1 in mice with colitis, which partly explained the alleviative efficacy of inosine on the intestinal barrier functions in mice with colitis. The gene discussed is CLDN1; the disease is colitis.